Second Person Dies in Latest Ebola Outbreak in DRC
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
Second Person Dies in Latest Ebola Outbreak in DRC
Second Person Dies in Latest Ebola Outbreak in DRC
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
The woman may have had a link to another person, who was married to an Ebola survivor and who died a few days previously in Democratic Republic of Congo.
The newly discovered microbe seems to be responsible for a mysterious neurological disease that has killed dozens of critically endangered Western chimpanzees.
Manipulating the production of new neurons can improve cognition in animal models of the disease, raising the possibility that figuring out a way for humans to make more neurons could make a difference for people with dementia.
Johnson & Johnson’s vaccine is less effective at preventing COVID-19 than other approved vaccines are, but experts say it could still be an important tool in curbing the pandemic.
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
Host vouchering, the practice of preserving species known to harbor infectious diseases, can be used to help determine a pathogen’s source, scientists say.
Laura Dattaro, Spectrum | Jan 18, 2021 | 10+ min read
Five collaborations involving autistic scientists and experts are advancing autism research, from lending support for theories of the condition to shoring up trials of new treatments.
A large study of UK healthcare workers finds that immunity after coronavirus infection lasts for months, but those with antibodies may still be able to carry and spread the virus upon reexposure.
From 2017 to 2018, cancer deaths dropped by 2.4 percent, the largest single-year improvement recorded in 70 years of American Cancer Society annual cancer reports.
Paul Cohen of the Rockefeller University describes his study of thousands of people, finding that the energy-burning tissue is tied to a lower risk of for several diseases, including type 2 diabetes, high blood pressure, and heart disease.